ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,941,362 | -26.2% | 787,979 | -0.9% | 0.00% | -50.0% |
Q4 2022 | $8,054,211 | +5.6% | 795,085 | +3.1% | 0.00% | 0.0% |
Q3 2022 | $7,627,000 | +3.9% | 771,244 | +11.8% | 0.00% | 0.0% |
Q2 2022 | $7,343,000 | +1181.5% | 689,538 | +2309.9% | 0.00% | – |
Q3 2021 | $573,000 | -70.7% | 28,613 | -67.8% | 0.00% | – |
Q2 2021 | $1,957,000 | – | 88,971 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |